23-25 October 2024

Rockville, MD - USA

Bayes 2024

DAY 1 – 23 October 2024

TIME
SPEAKER
AFFILIATION
08:30 - 09:00
Registration
12:30 - 13:30
Lunch
13:30 - 13:40
Welcome and Opening
Bruno Boulanger
Cencora PharmaLex
James Travis
FDA/CDER
Chair:
Bradley Carlin
Cencora PharmaLex
15:10 - 15:30
Michael Sonksen
Eli Lilly and Company
15:30 - 15:55
Coffee break
Chair:
Peter van de Ven
CBG-MEB
15:55 - 16:25
Peter F. Thall
MD Anderson Cancer Center
16:25 - 16:45
Steven Andrew Gilbert
Pfizer
Prediction of Overall Survival (OS) from Disease Progression Dynamics in Metastatic Cancer Trials
17:25 - 17:45
Robert Abugov
FDA/CDER
Aligning Bayesian Trial Designs with Expert Opinion: Some Rules of the Road

The BAYES Organising Committee is delighted to invite all registered delegates to the social dinner at Kumbia Restaurant at h. 19:00

DAY 2 – 24 October 2024

TIME
SPEAKER
AFFILIATION
Chair:
Astrid Jullion
Novartis
10:00 - 10:20
Laura Thompson
FDA/CDER
10:20 - 10:45
Coffee break
Chair:
Yong Zang
Indiana University
Chair:
Bruno Boulanger
Cencora PharmaLex
12:30 - 13:30
Lunch
Chair:
Bruno Boulanger
Cencora PharmaLex
14:20 - 14:40
Bill Pikounis
Johnson & Johnson
Comparability with Statistical Rigor in Manufacturing Development
14:40 - 15:00
Will Landau
Eli Lilly and Company
15:20 - 15:45
Coffee break
Chair:
Bradley Carlin
Cencora PharmaLex

DAY 3 – 25 October 2024

TIME
SPEAKER
AFFILIATION
Chair:
Ming-Dauh Wang
Bayer
10:30 - 10:55
Coffee break
Chair:
James Travis
FDA/CDER
11:25 -11:45
Mark Rothmann
FDA/CDER
12:45 - 12:55
Closing Remarks
Bruno Boulanger
Cencora PharmaLex
Peter van de Ven
CBG-MEB